Back to Jacobs Levy Equity Management, Inc. Jacobs Levy Equity Management, Inc.

TNGX

12 quarters

Position history for Jacobs Levy Equity Management, Inc.Jacobs Levy Equity Management, Inc.'s holdings in Tango Therapeutics, Inc.

No. Jacobs Levy Equity Management exited its TNGX (Tango Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 218,779 shares worth $1.1M. Jacobs Levy Equity Management first reported TNGX in Q3 2022 and held it in 10 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1.3M

Total Shares Change

-345,923

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$8.44
0
2025-Q2
Decreased
218,779
-70.3%
$1.1M0.0%$5.01
0
2025-Q1
Increased
737,955
+42.6%
$1M0.0%$1.47
34
2024-Q4
New
517,426
-
$1.6M0.0%$3.10
35
2024-Q2
Exited
0
-100.0%
$00.0%$8.58
0
2024-Q1
Decreased
21,338
-61.8%
$169,4240.0%$7.94
0
2023-Q4
Decreased
55,814
-61.1%
$552,5590.0%$9.90
0
2023-Q3
Decreased
143,481
-55.0%
$1.6M0.0%$11.26
0
2023-Q2
Decreased
318,776
-21.4%
$1.1M0.0%$3.26
0
2023-Q1
Increased
405,565
+17.1%
$1.6M0.0%$3.92
30
2022-Q4
Increased
346,471
+0.2%
$2.5M0.0%$7.25
26
2022-Q3
New
345,923
-
$1.3M0.0%$3.60
35

Other major holders of TNGX: RTW Investments, LP, BlackRock, Inc., FMR LLC, Farallon Capital Management, L.L.C., Goldman Sachs Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used